Sign in

You're signed outSign in or to get full access.

Joshua Markowitz

Chairman of the Board at VASO
Board

About Joshua Markowitz

Joshua Markowitz, age 69, is Chairman of the Board of Vaso Corporation and has served as a director since June 2015; he was appointed Chairman in August 2016 . He is a practicing attorney in New Jersey for more than 30 years and a senior partner at Markowitz O’Donnell, LLP; he also serves as President of Kerns Manufacturing Corporation, providing legal and operating expertise to the Board . The Board has determined he is independent under NASDAQ standards; he serves on and chairs the Compensation Committee, indicating an active governance role .

Past Roles

OrganizationRoleTenureCommittees/Impact
Vaso CorporationDirector; Chairman of the BoardDirector since June 2015; Chairman since Aug 2016 Compensation Committee Chair (2024), guiding executive pay decisions

External Roles

OrganizationRoleTenure/NotesCommittees/Impact
Markowitz O’Donnell, LLP (NJ)Senior PartnerPracticing attorney >30 years Legal expertise applicable to governance
Kerns Manufacturing CorporationPresidentCurrent (longstanding) Industrial operations perspective; interlock with Vaso board members

Board Governance

ItemDetails
Board class/tenureMarkowitz is a Class I director; term expires in 2027
IndependenceBoard determined Markowitz is independent under NASDAQ standards
CommitteesCompensation Committee (Chair: Markowitz; member: Movaseghi) met 2 times in 2024
Audit CommitteeMembers: Rios (Chair), Movaseghi; met 4 times in 2024
NominatingNo standing nominating committee; full Board acts as nominating committee (majority independent)
Board meetings8 meetings in 2024; all directors attended ≥75% of Board/committee meetings

Fixed Compensation

ComponentValueNotes
Chairman of the Board annual fee (Markowitz)$180,000Flat annual fee
Non-employee director annual retainer$50,000Applies to other non-employee directors
Meeting fees$2,500 per meetingBoard and committee meetings
Committee chair fee$5,000 per yearAdditional for committee chairs
2024 total for Markowitz$180,000No stock or option awards in 2024

Performance Compensation

InstrumentGrant detailsVesting2024 Markowitz grants
Restricted stockNo grants to Markowitz in 2024N/A$0
OptionsNone outstanding at 12/31/2024N/A$0
Equity plan availability2016 Plan remaining 531,361 shares; 2019 Plan remaining 8,350,000 shares as of 10/31/2025Board/Comp Committee discretionNot utilized for Markowitz in 2024

No director performance metrics (e.g., TSR, EBITDA targets) are disclosed for director pay; equity awards in 2024 were limited to a single grant to another director (Dembo: 150,000 shares; grant-date fair value $19,500) .

Other Directorships & Interlocks

EntityRelationshipInterlock/Notes
Kerns Manufacturing CorporationMarkowitz: PresidentMovaseghi (VASO director) is Kerns treasurer/secretary; operational/law firm ties noted
Markowitz O’Donnell, LLPMarkowitz: Senior PartnerLegal practice experience (>30 years)
Dr. Jun Ma (VASO CEO)Prior consulting to Kerns ManufacturingKerns and Living Data Technology Corp. are Vaso stockholders; Ma previously consulted to both

Related party transactions: Company reports no transactions above SEC thresholds with directors/officers or family members for the year ended 12/31/2024; Audit Committee reviews potential conflicts under charter .

Expertise & Qualifications

  • Legal expertise: Senior partner, long-term practice in NJ, corporate and operational understanding .
  • Industrial/operational experience: President of Kerns Manufacturing, contributing to oversight of operations and strategy .
  • Governance experience: Compensation Committee Chair, Board Chair, independent status per NASDAQ .

Equity Ownership

HolderShares Beneficially Owned% of OutstandingOwnership Breakdown
Joshua Markowitz56,088,31831.88%350,000 shares directly; 55,738,318 shares controlled by trust funds for which he is sole trustee
Officers & directors as a group (9)77,155,15543.85%Concentrated insider ownership/voting power

Equity awards outstanding: None as of 12/31/2024 (no options/unvested awards) . Pledging/hedging: Company states it does not have practices/policies restricting hedging transactions for employees or directors (insider trading clearance required, but no hedging prohibition) .

Governance Assessment

  • Independence and roles: Markowitz is Board Chair and deemed independent; serves as Compensation Committee Chair, which centralizes influence over pay while maintaining NASDAQ independence requirements .
  • Engagement: Board met 8 times in 2024; committees active; all directors achieved ≥75% attendance, supporting baseline engagement, though individual attendance rates are not disclosed .
  • Ownership alignment: Significant “skin in the game” with 31.88% ownership (mostly via trusts), aligning economic interests with shareholders but also concentrating voting control . Insider group control totals 43.85% voting power, a material governance signal for minority holders .
  • Compensation structure: Markowitz’s director compensation is entirely cash ($180,000) with no equity grants in 2024; while his large shareholding provides alignment, the director pay mix itself has limited at-risk/equity components .
  • Interlocks and potential conflicts: Dual roles tied to Kerns Manufacturing (Markowitz as President; Movaseghi as treasurer/secretary; Ma prior consulting; Kerns is a Vaso stockholder) create network interlocks; however, no reportable related-party transactions above SEC thresholds were disclosed for 2024, and the Audit Committee oversees conflicts .
  • Policy risk indicator: The company discloses no practices/policies restricting hedging transactions by employees or directors, which is misaligned with many governance best practices and can be a red flag for alignment .

RED FLAGS

  • Concentrated control: Officers/directors collectively hold 43.85% voting power; Markowitz individually holds 31.88%, raising minority shareholder influence risk .
  • Hedging policy: Company does not have practices/policies limiting hedging of company stock by employees/directors, which may dilute alignment incentives .
  • Interlocks: Overlapping roles with Kerns Manufacturing (a Vaso stockholder) involving multiple directors/executives increase perceived conflict potential, despite no reportable transactions in 2024 .